96 results on '"Ochoa-Sanchez, Rafael"'
Search Results
2. Selective Enhancement of REM Sleep in Male Rats through Activation of MT1Receptors Located in the Locus Coeruleus Norepinephrine neurons
3. Hepatic Encephalopathy: From Metabolic to Neurodegenerative
4. Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT1 Receptors Located in the Locus Ceruleus Norepinephrine Neurons.
5. P32 Multiple Ammonia-Induced Episodes of Hepatic Encephalopathy Provoke Neuronal Cell Loss in Bile-Duct Ligated Rats
6. Cerebral vasospasm as a consequence of pituitary apoplexy: illustrative case
7. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
8. Surgical Outcomes and Limitations of Expanded Endoscopic Endonasal Odontoidectomy
9. Diagnostic Accuracy of MRS in the Preoperative Identification of Isocitrate Dehydrogenase Mutation in Patients with Gliomas
10. The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis
11. Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
12. Utilization of Intraoperative Continuous Flash Visual Evoked Potentials in Endoscopic Skull Base Surgery
13. Superior Semicircular Canal Dehiscence Syndrome: The Ottawa Hospital Experience
14. Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile‐duct ligated rats
15. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
16. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT 2 receptors
17. An Investigation of PS‐ b ‐PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia
18. P: 82 Genetically Engineered E. coli Nissle Attenuates Hyperammonemia and Improves Memory in an Experimental Model of Cirrhosis and Hepatic Encephalopathy
19. P: 83 Obesity Accelerates and Exacerbates Neurological Impairments Associated to Hepatic Encephalopathy in Chronic Liver Disease
20. P: 50 Developing a New Animal Model of Episodic Hepatic Encephalopathy
21. Progressive resistance training prevents loss of muscle mass and strength in bile duct‐ligated rats
22. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT2 receptors.
23. Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease
24. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
25. Effects of Anaerobic Exercise in Muscle Strength and Muscle Mass Optimization in Bile Duct Ligated Rats
26. Development of a New Animal Model of Obesity and Chronic Liver Disease for the Study of Hepatic Encephalopathy
27. The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis
28. The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors
29. Hypnotic and Anxiolytic Properties of the Selective Melatonin MT2 Receptor Partial Agonist UCM765
30. Progressive resistance training prevents loss of muscle mass and strength in bile duct‐ligated rats.
31. A novel melatonin partial agonist with sleep-promoting properties
32. Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states
33. Reduction in cholinergic interneuron density in the nucleus accumbens attenuates local extracellular dopamine release in response to stress or amphetamine
34. Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2Melatonin Receptor Ligand
35. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood
36. M-B-035 SLEEP IN MT2 MELATONIN RECEPTOR KNOCKOUT MICE
37. Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states.
38. Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
39. Reduction in cholinergic interneuron density in the nucleus accumbens attenuates local extracellular dopamine release in response to stress or amphetamine.
40. Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
41. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood.
42. Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand.
43. Melancholic-Like Behaviors and Circadian Neurobiological Abnormalities in Melatonin MT1 Receptor Knockout Mice.
44. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.
45. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
46. Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states
47. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
48. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
49. Melancholic-Like Behaviors and Circadian Neurobiological Abnormalities in Melatonin MT1 Receptor Knockout Mice
50. Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT 1 Receptors Located in the Locus Ceruleus Norepinephrine Neurons.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.